Durvalumab for Small Cell Lung Cancer User Reviews
Brand names: Imfinzi
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Small Cell Lung Cancer
Care guides
Symptoms and treatments
More about durvalumab
- Check interactions
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Imfinzi (durvalumab) "3 to 4 days after I have a tightness in my chest, it does go away, I also have a rash on both arms. I have constipation. Now I am having trouble swallowing, the only thing I can swallow without difficulty is soft foods and liquids. I have to go and get an X-ray of my esophagus in September. Good news is the tumor continues to shrink. I just had a CT scan with contrast a couple of weeks ago. I do have to have a CT scan every 3 months. I believe Imfinzi is helping me."